Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies
| Autor: | Yong, W.P., Goh, B.C. *, Soo, R.A., Toh, H.C., Ethirajulu, K., Wood, J., Novotny-Diermayr, V., Lee, S.C., Yeo, W.L., Chan, D., Lim, D., Seah, E., Lim, R., Zhu, J. |
|---|---|
| Zdroj: | In Annals of Oncology November 2011 22(11):2516-2522 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|